Quality Of Life After Treatment For Bladder Cancer

Overview

About this study

The purpose of this study is to compare general and disease-specific quality of life outcomes at 6, 12, 24, and 36 months after treatment for localized bladder cancer using the PROMIS-29 and the Bladder Cancer Index (BCI) respectively and to identify patient level characteristics that may influence quality of life outcomes after treatment for localized bladder cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

≥ 18 years of age;
Have newly diagnosed, pathologically confirmed, clinically localized, bladder cancer;
Be willing to complete a survey in English before starting definitive treatment (surgery or radiation);
Able to give consent.

Exclusion Crtieria:

None.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Mark Tyson II, M.D., M.P.H.	Closed for enrollment	Contact information: Emily Stricklin (480) 574-2946 Stricklin.Emily@mayo.edu
Jacksonville, Fla. Mayo Clinic principal investigator	Closed for enrollment	Contact information: Cancer Center Clinical Trials Referral Office (855) 776-0015
Rochester, Minn. Mayo Clinic principal investigator Matthew Gettman, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Mark Tyson II, M.D., M.P.H.

Closed for enrollment

Contact information:

Emily Stricklin

(480) 574-2946

Stricklin.Emily@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

Rochester, Minn.

Mayo Clinic principal investigator

Matthew Gettman, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials